Correlation Between Bristol Myers and Adaptimmune Therapeutics
Can any of the company-specific risk be diversified away by investing in both Bristol Myers and Adaptimmune Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and Adaptimmune Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and Adaptimmune Therapeutics Plc, you can compare the effects of market volatilities on Bristol Myers and Adaptimmune Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of Adaptimmune Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and Adaptimmune Therapeutics.
Diversification Opportunities for Bristol Myers and Adaptimmune Therapeutics
-0.23 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Bristol and Adaptimmune is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Adaptimmune Therapeutics Plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adaptimmune Therapeutics and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Adaptimmune Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adaptimmune Therapeutics has no effect on the direction of Bristol Myers i.e., Bristol Myers and Adaptimmune Therapeutics go up and down completely randomly.
Pair Corralation between Bristol Myers and Adaptimmune Therapeutics
Considering the 90-day investment horizon Bristol Myers Squibb is expected to generate 0.64 times more return on investment than Adaptimmune Therapeutics. However, Bristol Myers Squibb is 1.56 times less risky than Adaptimmune Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Adaptimmune Therapeutics Plc is currently generating about -0.02 per unit of risk. If you would invest 5,681 in Bristol Myers Squibb on November 9, 2024 and sell it today you would earn a total of 61.00 from holding Bristol Myers Squibb or generate 1.07% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Bristol Myers Squibb vs. Adaptimmune Therapeutics Plc
Performance |
| Timeline |
| Bristol Myers Squibb |
| Adaptimmune Therapeutics |
Bristol Myers and Adaptimmune Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bristol Myers and Adaptimmune Therapeutics
The main advantage of trading using opposite Bristol Myers and Adaptimmune Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, Adaptimmune Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adaptimmune Therapeutics will offset losses from the drop in Adaptimmune Therapeutics' long position.| Bristol Myers vs. AbbVie Inc | Bristol Myers vs. Merck Company | Bristol Myers vs. Gilead Sciences | Bristol Myers vs. Johnson Johnson |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Stocks Directory Find actively traded stocks across global markets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |